Literature DB >> 22640876

Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating.

M W Pitts1, A V Raman, A C Hashimoto, C Todorovic, R A Nichols, M J Berry.   

Abstract

One of the primary lines of defense against oxidative stress is the selenoprotein family, a class of proteins that contain selenium in the form of the 21st amino acid, selenocysteine. Within this class of proteins, selenoprotein P (Sepp1) is unique, as it contains multiple selenocysteine residues and is postulated to act in selenium transport. Recent findings have demonstrated that neuronal selenoprotein synthesis is required for the development of parvalbumin (PV)-interneurons, a class of GABAergic neurons involved in the synchronization of neural activity. To investigate the potential influence of Sepp1 on PV-interneurons, we first mapped the distribution of the Sepp1 receptor, ApoER2, and parvalbumin in the mouse brain. Our results indicate that ApoER2 is highly expressed on PV-interneurons in multiple brain regions. Next, to determine whether PV-interneuron populations are affected by Sepp1 deletion, we performed stereology on several brain regions in which we observed ApoER2 expression on PV-interneurons, comparing wild-type and Sepp1(-/-) mice. We observed reduced numbers of PV-interneurons in the inferior colliculus of Sepp1(-/-) mice, which corresponded with a regional increase in oxidative stress. Finally, as impaired PV-interneuron function has been implicated in several neuropsychiatric conditions, we performed multiple behavioral tests on Sepp1(-/-) mice. Our behavioral results indicate that Sepp1(-/-) mice have impairments in contextual fear extinction, latent inhibition, and sensorimotor gating. In sum, these findings demonstrate the important supporting role of Sepp1 on ApoER2-expressing PV-interneurons. Copyright Â
© 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22640876      PMCID: PMC3362796          DOI: 10.1016/j.neuroscience.2012.02.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  44 in total

1.  Progression of neurodegeneration and morphologic changes in the brains of juvenile mice with selenoprotein P deleted.

Authors:  Samuel W Caito; Dejan Milatovic; Kristina E Hill; Michael Aschner; Raymond F Burk; William M Valentine
Journal:  Brain Res       Date:  2011-05-05       Impact factor: 3.252

Review 2.  Redox dysregulation, neurodevelopment, and schizophrenia.

Authors:  Kim Q Do; Jan H Cabungcal; Anita Frank; Pascal Steullet; Michel Cuenod
Journal:  Curr Opin Neurobiol       Date:  2009-05-27       Impact factor: 6.627

3.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

4.  Unilateral electrical stimulation of the inferior colliculus of rats modifies the prepulse modulation of the startle response (PPI): effects of ketamine and diazepam.

Authors:  R C B Silva; G Sandner; M L Brandão
Journal:  Behav Brain Res       Date:  2005-01-18       Impact factor: 3.332

5.  Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia.

Authors:  P Steullet; H C Neijt; M Cuénod; K Q Do
Journal:  Neuroscience       Date:  2005-12-05       Impact factor: 3.590

Review 6.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

7.  Extinction memory is impaired in schizophrenia.

Authors:  Daphne J Holt; Kelimer Lebron-Milad; Mohammed R Milad; Scott L Rauch; Roger K Pitman; Scott P Orr; Brittany S Cassidy; Jared P Walsh; Donald C Goff
Journal:  Biol Psychiatry       Date:  2008-11-04       Impact factor: 13.382

8.  Decreased effectiveness of GABA-mediated inhibition in the inferior colliculus of the genetically epilepsy-prone rat.

Authors:  C L Faingold; G Gehlbach; D M Caspary
Journal:  Exp Neurol       Date:  1986-07       Impact factor: 5.330

9.  Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.

Authors:  Eva K Wirth; Marcus Conrad; Jochen Winterer; Christian Wozny; Bradley A Carlson; Stephan Roth; Dietmar Schmitz; Georg W Bornkamm; Vincenzo Coppola; Lino Tessarollo; Lutz Schomburg; Josef Köhrle; Dolph L Hatfield; Ulrich Schweizer
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

10.  NMDA receptor channels: subunit-specific potentiation by reducing agents.

Authors:  G Köhr; S Eckardt; H Lüddens; H Monyer; P H Seeburg
Journal:  Neuron       Date:  1994-05       Impact factor: 17.173

View more
  27 in total

1.  Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration.

Authors:  Raymond F Burk; Kristina E Hill; Amy K Motley; Virginia P Winfrey; Suguru Kurokawa; Stuart L Mitchell; Wanqi Zhang
Journal:  FASEB J       Date:  2014-04-23       Impact factor: 5.191

Review 2.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

3.  Perineuronal nets protect fast-spiking interneurons against oxidative stress.

Authors:  Jan-Harry Cabungcal; Pascal Steullet; Hirofumi Morishita; Rudolf Kraftsik; Michel Cuenod; Takao K Hensch; Kim Q Do
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

4.  Impaired selenoprotein expression in brain triggers striatal neuronal loss leading to co-ordination defects in mice.

Authors:  Sandra Seeher; Bradley A Carlson; Angela C Miniard; Eva K Wirth; Yassin Mahdi; Dolph L Hatfield; Donna M Driscoll; Ulrich Schweizer
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

Review 5.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

6.  Uptake and Utilization of Selenium from Selenoprotein P.

Authors:  Sumangala Shetty; John R Marsicano; Paul R Copeland
Journal:  Biol Trace Elem Res       Date:  2017-05-09       Impact factor: 3.738

7.  Ribosome profiling of selenoproteins in vivo reveals consequences of pathogenic Secisbp2 missense mutations.

Authors:  Wenchao Zhao; Simon Bohleber; Henrik Schmidt; Sandra Seeher; Michael T Howard; Doreen Braun; Simone Arndt; Uschi Reuter; Hagen Wende; Carmen Birchmeier; Noelia Fradejas-Villar; Ulrich Schweizer
Journal:  J Biol Chem       Date:  2019-07-26       Impact factor: 5.157

8.  Deficits in Glutamic Acid Decarboxylase 67 Immunoreactivity, Parvalbumin Interneurons, and Perineuronal Nets in the Inferior Colliculus of Subjects With Schizophrenia.

Authors:  Victor W Kilonzo; Robert A Sweet; Jill R Glausier; Matthew W Pitts
Journal:  Schizophr Bull       Date:  2020-07-18       Impact factor: 9.306

9.  Deletion of selenoprotein M leads to obesity without cognitive deficits.

Authors:  Matthew W Pitts; Mariclair A Reeves; Ann C Hashimoto; Ashley Ogawa; Penny Kremer; Lucia A Seale; Marla J Berry
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

10.  JIP1-Mediated JNK Activation Negatively Regulates Synaptic Plasticity and Spatial Memory.

Authors:  Caroline Morel; Tessi Sherrin; Norman J Kennedy; Kelly H Forest; Seda Avcioglu Barutcu; Michael Robles; Ezekiel Carpenter-Hyland; Naghum Alfulaij; Claire L Standen; Robert A Nichols; Morris Benveniste; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.